Lethal effect of hyperthermochemoradiotherapy on cultured transformed cells. 1988

H Matsuoka, and K Sugimachi, and H Ueo, and H Kuwano, and H Kai, and Y Okudaira, and S Nakano
Department of Surgery II, Faculty of Medicine, Kyushu University, Fukuoka, Japan.

Hyperthermia alone had a lethal effect on V-79 cells. Temporary exposure to hyperthermia resulted in substantial decreases in cell growth, in a time (20-120 min)- and temperature (39-44 degrees C)-dependent manner. A precipitous fall in cell growth occurred when cells were incubated at temperatures between 42 and 43 degrees C. Concomitant application of hyperthermia, bleomycin and irradiation (hyperthermochemoradiotherapy) led to a maximal effect, compared with findings in cells treated with a single or two modalities, in vitro as well as in vivo and in clinical cases. To produce a similar situation of tumor cell growth in vivo, multicellular tumor spheroids (MTS) were developed by culturing tumor cells on soft agar. The effect of various treatments on the cells was then determined. Hyperthermia had a greater effect on the inner layer (hypoxic state) of MTS than on the outer layer, while radiotherapy was more effective on the outer layer (aerobic state). The synergistic effect of the combination with hyperthermia and irradiation was exhibited in all layers of MTS. Hyperthermochemoradiotherapy may prove to be an effective and safe form of adjuvant therapy for treating clinical carcinoma.

UI MeSH Term Description Entries
D001761 Bleomycin A complex of related glycopeptide antibiotics from Streptomyces verticillus consisting of bleomycin A2 and B2. It inhibits DNA metabolism and is used as an antineoplastic, especially for solid tumors. BLEO-cell,Blanoxan,Blenoxane,Bleolem,Bleomicina,Bleomycin A(2),Bleomycin A2,Bleomycin B(2),Bleomycin B2,Bleomycin Sulfate,Bleomycins,Bleomycinum Mack,Bléomycine Bellon,BLEO cell,BLEOcell,Bellon, Bléomycine,Mack, Bleomycinum,Sulfate, Bleomycin
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D006358 Hot Temperature Presence of warmth or heat or a temperature notably higher than an accustomed norm. Heat,Hot Temperatures,Temperature, Hot,Temperatures, Hot
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured

Related Publications

H Matsuoka, and K Sugimachi, and H Ueo, and H Kuwano, and H Kai, and Y Okudaira, and S Nakano
June 1970, The Journal of antibiotics,
H Matsuoka, and K Sugimachi, and H Ueo, and H Kuwano, and H Kai, and Y Okudaira, and S Nakano
June 1972, Gan,
H Matsuoka, and K Sugimachi, and H Ueo, and H Kuwano, and H Kai, and Y Okudaira, and S Nakano
October 1980, Gan,
H Matsuoka, and K Sugimachi, and H Ueo, and H Kuwano, and H Kai, and Y Okudaira, and S Nakano
August 1967, Acta pathologica japonica,
H Matsuoka, and K Sugimachi, and H Ueo, and H Kuwano, and H Kai, and Y Okudaira, and S Nakano
July 1976, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
H Matsuoka, and K Sugimachi, and H Ueo, and H Kuwano, and H Kai, and Y Okudaira, and S Nakano
January 1988, Scientia Sinica. Series B, Chemical, biological, agricultural, medical & earth sciences,
H Matsuoka, and K Sugimachi, and H Ueo, and H Kuwano, and H Kai, and Y Okudaira, and S Nakano
July 1983, Gan no rinsho. Japan journal of cancer clinics,
H Matsuoka, and K Sugimachi, and H Ueo, and H Kuwano, and H Kai, and Y Okudaira, and S Nakano
November 1961, Annals of the New York Academy of Sciences,
H Matsuoka, and K Sugimachi, and H Ueo, and H Kuwano, and H Kai, and Y Okudaira, and S Nakano
January 1989, International journal of radiation biology,
H Matsuoka, and K Sugimachi, and H Ueo, and H Kuwano, and H Kai, and Y Okudaira, and S Nakano
October 1984, Neurologia medico-chirurgica,
Copied contents to your clipboard!